Osteoblastoma

Changed by Joachim Feger, 27 May 2022
Disclosures - updated 8 May 2022: Nothing to disclose

Updates to Article Attributes

Body was changed:

Osteoblastomas are rare bone-forming tumours that may be locally aggressive. They are larger (>2 cm) and tend to affect the axial skeleton more often than their histologic relative, osteoid osteoma 41.

Terminology

‘Epithelioid osteoblastoma’ is considered an acceptable alternative term 1.

The terms 'pseudomalignant osteoblastoma' or 'aggressive osteoblastoma' are no longer recommended 1.

Epidemiology

TheyOsteoblastomas account for 1-3≤1% of all primary bone tumours 2,31-4. Patients typically present around the second to third decades of life1. There is a recognised male predilection with men approximately two times more commonly affected than women 1.

Diagnosis

The diagnosis of osteoblastoma is based on a malecombination of typical radiological and pathological features.

Diagnostic criteria

Diagnostic criteria according to female ratiothe WHO classification of approximately 2.5:1.soft tissue and bone tumours (5thedition)1:

Essential features include 1:

  • lytic bone tumour >2 cm in size on imaging
  • well defined tumour borders
  • no evidence of permeation of the host bone
  • histological evidence of a bone-forming tumour consisting of trabeculae of remodelled woven bone framed by plump osteoblasts in a vascularised background

Clinical presentation

With spinal lesions, painful scoliosis is a common presenting symptom. Otherwise, it presentsOsteoblastomas commonly present with an insidious onset of dull pain, worse at night, with minimal response to salicylates (only 7% of patients respond, unlike osteoid osteoma)1. The area will characteristically be swollen and tender with a decreased range of motion.

Spinal lesions might present with painful scoliosis or neurological symptoms 1

Pathology

Osteoblastomas are histologically similar to osteoid osteomas, are bone- and osteoid-forming with a rim of osteoblasts and are associated richly vascularity 121.

Location
  • spinal column: ~40% (range 32-46% 2); often involves the posterior column
    • cervical spine: 9-39% of all spinal osteoblastomas 25 
    • sacrum: 17% of all spinal osteoblastomas 36
  • usually located in the metaphysis and distal diaphysis of the long bones
Variants
  • aggressive (malignant) osteoblastoma
    • has a high of number epithelioid osteoblasts with nuclear atypia
    • controversial diagnosis, not recommended by the WHO 121
    • epithelioid osteoblastoma is the preferred term 121
Genetics
  • FOS gene rearrangement is present in ~90% of cases (similar to osteoid osteoma) 121

Radiographic features

Osteoblastomas can have a wide range of radiographic patterns. Lesions are typically larger than 1.5-2 cm in size although smaller lesions may occur 4,57,8

Plain radiograph
  • lesions are predominantly lytic, with a rim of reactive sclerosis
  • tend to be expansive
  • may have a bubbly appearance 47
  • internal calcification may sometimes be present
  • an associated soft tissue mass may also be present
  • demonstrate a rapid increase in size with associated cortical expansion in the vast majority of patients, sometimes with cortical destruction
  • there may be surrounding sclerosis or periostitis in up to 50%
  • there may be a secondary aneurysmal bone cyst-like changes in 20%
CT 
  • similar to the radiograph, lesions are often demonstrated as predominantly lytic 
  • internal matrix mineralisation is better appreciated on CT
MRI

MRI features tend to be non-specific and often overestimate the lesion 9:

  • T1: typically hypo to isointense on T1 with areas of decreased intensity that correspond to foci of calcification
  • T2: typically isointense to hypointense on T2 with foci of decreased intensity corresponding to the foci of calcification
    • a high signal may be seen in surrounding bone marrow and soft tissues due to oedema "flare phenomenon" 1110
  • C+ (Gd): this is a highly vascular tumour and therefore typically avidly enhances, with associated enhancement of the surrounding soft tissues 9
Nuclear medicine
  • Tc-99m MDP or HMDL: often shows intense uptake although this is non-specific and is typical in all lesions exhibiting increased bone turnover

Radiology report

The radiological report should include a description of the following 11:

  • location and size
  • tumour margins and transition zone
  • aneurysmal bone cyst-like changes
  • concerning features
    • pathologic fracture
    • cortical destruction
    • aggressive periosteal reaction
    • surrounding bone marrow oedema
    • solid mass like enhancement
    • soft tissue extension

If features are typical the lesion should be categorised as Bone-RADS 4 on CT or MRI 11.

Treatment and prognosis

En bloc surgical excision is often the treatment of choice ref with curettage another surgical option 121. Pre-operative embolisation is commonly carried out to reduce bleeding risk although surgery needs to be performed at a very short time interval in order to avoid reconstitution of collateral blood supply ref. Percutaneous ablation is an emerging modality for the treatment of these lesions (as well as osteoid osteoma) 1011. Recurrence rates may be as high as ~25~23% 121.

Complications

Lesions are prone to extensive intraoperative bleeding due to intrinsic vascularity ref.

Differential diagnosis

Differential diagnoses of osteoblastomas include 4:

  • -<p><strong>Osteoblastomas</strong> are rare <a href="/articles/bone-forming-tumours-1">bone-forming tumours</a> that may be locally aggressive. They are larger (&gt;2 cm) and tend to affect the axial skeleton more often than their histologic relative, <a href="/articles/osteoid-osteoma">osteoid osteoma</a> <sup>4</sup>.</p><h4>Epidemiology</h4><p>They account for 1-3% of all primary bone tumours <sup>2,3</sup>. Patients typically present around the second to third decades of life. There is a recognised male predilection with a male to female ratio of approximately 2.5:1.</p><h4>Clinical presentation</h4><p>With spinal lesions, painful scoliosis is a common presenting symptom. Otherwise, it presents with an insidious onset of dull pain, worse at night, with minimal response to salicylates (only 7% of patients respond, unlike <a href="/articles/osteoid-osteoma">osteoid osteoma</a>). The area will characteristically be swollen and tender with a decreased range of motion.</p><h4>Pathology</h4><p>Osteoblastomas are histologically similar to <a href="/articles/osteoid-osteoma">osteoid osteomas</a>, are bone- and osteoid-forming with a rim of osteoblasts and associated richly vascularity <sup>12</sup>.</p><h5>Location</h5><ul>
  • +<p><strong>Osteoblastomas</strong> are rare <a href="/articles/bone-forming-tumours-1">bone-forming tumours</a> that may be locally aggressive. They are larger (&gt;2 cm) and tend to affect the axial skeleton more often than their histologic relative, <a href="/articles/osteoid-osteoma">osteoid osteoma</a> <sup>1</sup>.</p><h4>Terminology</h4><p>‘Epithelioid osteoblastoma’ is considered an acceptable alternative term <sup>1</sup>.</p><p>The terms 'pseudomalignant osteoblastoma' or 'aggressive osteoblastoma' are no longer recommended <sup>1</sup>.</p><h4>Epidemiology</h4><p>Osteoblastomas account for ≤1% of all primary bone tumours <sup>1-4</sup>. Patients typically present around the second to third decades of life <sup>1</sup>. There is a recognised male predilection with men approximately two times more commonly affected than women <sup>1</sup>.</p><h4>Diagnosis</h4><p>The diagnosis of osteoblastoma is based on a combination of typical radiological and pathological features.</p><h5>Diagnostic criteria</h5><p>Diagnostic criteria according to the <a href="/articles/who-classification-of-tumors-of-bone">WHO classification of soft tissue and bone tumours (5<sup>th</sup>edition)</a> <sup>1</sup>:</p><p>Essential features include <sup>1</sup>:</p><ul>
  • +<li>lytic bone tumour &gt;2 cm in size on imaging</li>
  • +<li>well defined tumour borders</li>
  • +<li>no evidence of permeation of the host bone</li>
  • +<li>histological evidence of a bone-forming tumour consisting of trabeculae of remodelled woven bone framed by plump osteoblasts in a vascularised background</li>
  • +</ul><h4>Clinical presentation</h4><p>Osteoblastomas commonly present with an insidious onset of dull pain, worse at night, with minimal response to salicylates (only 7% of patients respond, unlike <a href="/articles/osteoid-osteoma">osteoid osteoma</a>) <sup>1</sup>. The area will characteristically be swollen and tender with a decreased range of motion.</p><p>Spinal lesions might present with painful scoliosis or neurological symptoms <sup>1</sup>. </p><h4>Pathology</h4><p>Osteoblastomas are histologically similar to <a href="/articles/osteoid-osteoma">osteoid osteomas</a>, are bone- and osteoid-forming with a rim of osteoblasts and are associated richly vascularity <sup>1</sup>.</p><h5>Location</h5><ul>
  • -<li>cervical spine: 9-39% of all spinal osteoblastomas <sup>2</sup> </li>
  • +<li>cervical spine: 9-39% of all spinal osteoblastomas <sup>5</sup> </li>
  • -<a href="/articles/sacrum">sacrum</a>: 17% of all spinal osteoblastomas <sup>3</sup>
  • +<a href="/articles/sacrum">sacrum</a>: 17% of all spinal osteoblastomas <sup>6</sup>
  • -<li>controversial diagnosis, not recommended by the WHO <sup>12</sup>
  • +<li>controversial diagnosis, not recommended by the WHO <sup>1</sup>
  • -<li>epithelioid osteoblastoma is the preferred term <sup>12</sup>
  • +<li>epithelioid osteoblastoma is the preferred term <sup>1</sup>
  • -<em>FOS</em> gene rearrangement is present in ~90% of cases (similar to osteoid osteoma) <sup>12</sup>
  • -</li></ul><h4>Radiographic features</h4><p>Osteoblastomas can have a wide range of radiographic patterns. Lesions are typically larger than 1.5-2 cm in size although smaller lesions may occur <sup>4,5</sup>. </p><h5>Plain radiograph</h5><ul>
  • +<em>FOS</em> gene rearrangement is present in ~90% of cases (similar to osteoid osteoma) <sup>1</sup>
  • +</li></ul><h4>Radiographic features</h4><p>Osteoblastomas can have a wide range of radiographic patterns. Lesions are typically larger than 1.5-2 cm in size although smaller lesions may occur <sup>7,8</sup>. </p><h5>Plain radiograph</h5><ul>
  • -<li>may have a bubbly appearance <sup>4</sup>
  • +<li>may have a bubbly appearance <sup>7</sup>
  • -<li>there may be a secondary <a href="/articles/aneurysmal-bone-cyst">aneurysmal bone cyst</a> in 20%</li>
  • +<li>there may be a secondary aneurysmal bone cyst-like changes in 20%</li>
  • -<strong>T2:</strong> typically isointense to hypointense on T2 with foci of decreased intensity corresponding to the foci of calcification<ul><li>a high signal may be seen in surrounding bone marrow and soft tissues due to oedema "flare phenomenon" <sup>11</sup>
  • +<strong>T2:</strong> typically isointense to hypointense on T2 with foci of decreased intensity corresponding to the foci of calcification<ul><li>a high signal may be seen in surrounding bone marrow and soft tissues due to oedema "flare phenomenon" <sup>10</sup>
  • -<a href="/articles/technetium-99m-methyl-diphosphonate">Tc-99m MDP</a> or HMDL: often shows intense uptake although this is non-specific and is typical in all lesions exhibiting increased bone turnover</li></ul><h4>Treatment and prognosis</h4><p>En bloc surgical excision is often the treatment of choice <sup>ref</sup> with curettage another surgical option <sup>12</sup>. Pre-operative embolisation is commonly carried out to reduce bleeding risk although surgery needs to be performed at a very short time interval in order to avoid reconstitution of collateral blood supply <sup>ref</sup>. Percutaneous ablation is an emerging modality for treatment of these lesions (as well as osteoid osteoma) <sup>10</sup>. Recurrence rates may be as high as ~25% <sup>12</sup>.</p><h5>Complications</h5><p>Lesions are prone to extensive intraoperative bleeding due to intrinsic vascularity <sup>ref</sup>.</p><h4>Differential diagnosis</h4><ul><li>
  • -<a href="/articles/osteoid-osteoma">osteoid osteoma</a>: &lt;2 cm</li></ul>
  • +<a href="/articles/technetium-99m-methyl-diphosphonate">Tc-99m MDP</a> or HMDL: often shows intense uptake although this is non-specific and is typical in all lesions exhibiting increased bone turnover</li></ul><h4>Radiology report</h4><p>The radiological report should include a description of the following <sup>11</sup>:</p><ul>
  • +<li>location and size</li>
  • +<li>tumour margins and transition zone</li>
  • +<li>aneurysmal bone cyst-like changes</li>
  • +<li>concerning features<ul>
  • +<li><a title="Pathologic fracture" href="/articles/pathological-fracture">pathologic fracture</a></li>
  • +<li>cortical destruction</li>
  • +<li>aggressive periosteal reaction</li>
  • +<li>surrounding bone marrow oedema</li>
  • +<li>solid mass like enhancement</li>
  • +<li>soft tissue extension</li>
  • +</ul>
  • +</li>
  • +</ul><p>If features are typical the lesion should be categorised as <a title="Bone Reporting and Data System (Bone-RADS)" href="/articles/bone-reporting-and-data-system-bone-rads-1">Bone-RADS 4</a> on CT or MRI <sup>11</sup>.</p><h4>Treatment and prognosis</h4><p>En bloc surgical excision is often the treatment of choice <sup>ref</sup> with curettage another surgical option <sup>1</sup>. Pre-operative embolisation is commonly carried out to reduce bleeding risk although surgery needs to be performed at a very short time interval in order to avoid reconstitution of collateral blood supply <sup>ref</sup>. Percutaneous ablation is an emerging modality for the treatment of these lesions (as well as osteoid osteoma) <sup>11</sup>. Recurrence rates may be as high as ~23% <sup>1</sup>.</p><h5>Complications</h5><p>Lesions are prone to extensive intraoperative bleeding due to intrinsic vascularity <sup>ref</sup>.</p><h4>Differential diagnosis</h4><p>Differential diagnoses of osteoblastomas include <sup>4</sup>:</p><ul>
  • +<li>
  • +<a href="/articles/osteoid-osteoma">osteoid osteoma</a>: &lt;2 cm</li>
  • +<li><a href="/articles/aneurysmal-bone-cyst">aneurysmal bone cyst</a></li>
  • +<li><a href="/articles/giant-cell-tumour-of-bone">giant cell tumour of bone</a></li>
  • +<li>osteoma with osteoblastoma-like features</li>
  • +<li><a href="/articles/osteosarcoma">osteosarcoma</a></li>
  • +</ul>

References changed:

  • 18. McLeod R, Dahlin D, Beabout J. The Spectrum of Osteoblastoma. AJR Am J Roentgenol. 1976;126(2):321-5. <a href="https://doi.org/10.2214/ajr.126.2.321">doi:10.2214/ajr.126.2.321</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/175701">Pubmed</a>
  • 18. McLeod R, Dahlin D, Beabout J. The Spectrum of Osteoblastoma. AJR Am J Roentgenol. 1976;126(2):321-5. <a href="https://doi.org/10.2214/ajr.126.2.321">doi:10.2214/ajr.126.2.321</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/175701">Pubmed</a>
  • 5. Trübenbach J, Nägele T, Bauer T, Ernemann U. Preoperative Embolization of Cervical Spine Osteoblastomas: Report of Three Cases. AJNR Am J Neuroradiol. 2006;27(9):1910-2. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977911">PMC7977911</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/17032864">Pubmed</a>
  • 6. Llauger J, Palmer J, Amores S, Bagué S, Camins A. Primary Tumors of the Sacrum: Diagnostic Imaging. AJR Am J Roentgenol. 2000;174(2):417-24. <a href="https://doi.org/10.2214/ajr.174.2.1740417">doi:10.2214/ajr.174.2.1740417</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/10658718">Pubmed</a>
  • 7. Eisenberg R. Bubbly Lesions of Bone. AJR Am J Roentgenol. 2009;193(2):W79-94. <a href="https://doi.org/10.2214/AJR.09.2964">doi:10.2214/AJR.09.2964</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/19620421">Pubmed</a>
  • 8. Rodriguez D & Poussaint T. Imaging of Back Pain in Children. AJNR Am J Neuroradiol. 2010;31(5):787-802. <a href="https://doi.org/10.3174/ajnr.A1832">doi:10.3174/ajnr.A1832</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/19926701">Pubmed</a>
  • 19. Kroon H & Schurmans J. Osteoblastoma: Clinical and Radiologic Findings in 98 New Cases. Radiology. 1990;175(3):783-90. <a href="https://doi.org/10.1148/radiology.175.3.2343130">doi:10.1148/radiology.175.3.2343130</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/2343130">Pubmed</a>
  • 19. Kroon H & Schurmans J. Osteoblastoma: Clinical and Radiologic Findings in 98 New Cases. Radiology. 1990;175(3):783-90. <a href="https://doi.org/10.1148/radiology.175.3.2343130">doi:10.1148/radiology.175.3.2343130</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/2343130">Pubmed</a>
  • 20. Cerase A & Priolo F. Skeletal Benign Bone-Forming Lesions. Eur J Radiol. 1998;27 Suppl 1:S91-7. <a href="https://doi.org/10.1016/s0720-048x(98)00049-7">doi:10.1016/s0720-048x(98)00049-7</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/9652508">Pubmed</a>
  • 20. Cerase A & Priolo F. Skeletal Benign Bone-Forming Lesions. Eur J Radiol. 1998;27 Suppl 1:S91-7. <a href="https://doi.org/10.1016/s0720-048x(98)00049-7">doi:10.1016/s0720-048x(98)00049-7</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/9652508">Pubmed</a>
  • 21. Youssef B, Haddad M, Zahrani A et al. Osteoid Osteoma and Osteoblastoma: MRI Appearances and the Significance of Ring Enhancement. Eur Radiol. 1996;6(3):291-6. <a href="https://doi.org/10.1007/BF00180597">doi:10.1007/BF00180597</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/8797998">Pubmed</a>
  • 21. Youssef B, Haddad M, Zahrani A et al. Osteoid Osteoma and Osteoblastoma: MRI Appearances and the Significance of Ring Enhancement. Eur Radiol. 1996;6(3):291-6. <a href="https://doi.org/10.1007/BF00180597">doi:10.1007/BF00180597</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/8797998">Pubmed</a>
  • 1. WHO Classification of Tumours Editorial Board. WHO Classification of Tumours, 5th Edition. Soft Tissue and Bone Tumours. (2020) ISBN: 9789283245025 - <a href="https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Soft-Tissue-And-Bone-Tumours-2020">IARC Publications</a>
  • 2. Lucas D, Unni K, McLeod R, O'Connor M, Sim F. Osteoblastoma: Clinicopathologic Study of 306 Cases. Hum Pathol. 1994;25(2):117-34. <a href="https://doi.org/10.1016/0046-8177(94)90267-4">doi:10.1016/0046-8177(94)90267-4</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/8119712">Pubmed</a>
  • 3. Berry M, Mankin H, Gebhardt M, Rosenberg A, Hornicek F. Osteoblastoma: A 30-Year Study of 99 Cases. J Surg Oncol. 2008;98(3):179-83. <a href="https://doi.org/10.1002/jso.21105">doi:10.1002/jso.21105</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/18561158">Pubmed</a>
  • 4. Lucas D. Osteoblastoma. Archives of Pathology & Laboratory Medicine. 2010;134(10):1460-6. <a href="https://doi.org/10.5858/2010-0201-cr.1">doi:10.5858/2010-0201-cr.1</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/20923301">Pubmed</a>
  • 12. Atesok K, Alman B, Schemitsch E, Peyser A, Mankin H. Osteoid Osteoma and Osteoblastoma. J Am Acad Orthop Surg. 2011;19(11):678-89. <a href="https://doi.org/10.5435/00124635-201111000-00004">doi:10.5435/00124635-201111000-00004</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/22052644">Pubmed</a>
  • 10. Crim J, Mirra J, Eckardt J, Seeger L. Widespread Inflammatory Response to Osteoblastoma: The Flare Phenomenon. Radiology. 1990;177(3):835-6. <a href="https://doi.org/10.1148/radiology.177.3.2243998">doi:10.1148/radiology.177.3.2243998</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/2243998">Pubmed</a>
  • 11. Chang C, Garner H, Ahlawat S et al. Society of Skeletal Radiology- White Paper. Guidelines for the Diagnostic Management of Incidental Solitary Bone Lesions on CT and MRI in Adults: Bone Reporting and Data System (Bone-RADS). Skeletal Radiol. 2022;51(9):1743-64. <a href="https://doi.org/10.1007/s00256-022-04022-8">doi:10.1007/s00256-022-04022-8</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/35344076">Pubmed</a>
  • 12. WHO Classification of Tumours Editorial Board, Who Classification of Tumours Editorial. Soft Tissue and Bone Tumours. (2020) ISBN: 9789283245025 - <a href="http://books.google.com/books?vid=ISBN9789283245025">Google Books</a>
  • 1. McLeod R, Dahlin D, Beabout J. The Spectrum of Osteoblastoma. AJR Am J Roentgenol. 1976;126(2):321-5. <a href="https://doi.org/10.2214/ajr.126.2.321">doi:10.2214/ajr.126.2.321</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/175701">Pubmed</a>
  • 12. McLeod R, Dahlin D, Beabout J. The Spectrum of Osteoblastoma. AJR Am J Roentgenol. 1976;126(2):321-5. <a href="https://doi.org/10.2214/ajr.126.2.321">doi:10.2214/ajr.126.2.321</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/175701">Pubmed</a>
  • 2. Trübenbach J, Nägele T, Bauer T, Ernemann U. Preoperative Embolization of Cervical Spine Osteoblastomas: Report of Three Cases. AJNR Am J Neuroradiol. 2006;27(9):1910-2. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977911">PMC7977911</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/17032864">Pubmed</a>
  • 3. Llauger J, Palmer J, Amores S, Bagué S, Camins A. Primary Tumors of the Sacrum: Diagnostic Imaging. AJR Am J Roentgenol. 2000;174(2):417-24. <a href="https://doi.org/10.2214/ajr.174.2.1740417">doi:10.2214/ajr.174.2.1740417</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/10658718">Pubmed</a>
  • 4. Eisenberg R. Bubbly Lesions of Bone. AJR Am J Roentgenol. 2009;193(2):W79-94. <a href="https://doi.org/10.2214/AJR.09.2964">doi:10.2214/AJR.09.2964</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/19620421">Pubmed</a>
  • 5. Rodriguez D & Poussaint T. Imaging of Back Pain in Children. AJNR Am J Neuroradiol. 2010;31(5):787-802. <a href="https://doi.org/10.3174/ajnr.A1832">doi:10.3174/ajnr.A1832</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/19926701">Pubmed</a>
  • 6. Kroon H & Schurmans J. Osteoblastoma: Clinical and Radiologic Findings in 98 New Cases. Radiology. 1990;175(3):783-90. <a href="https://doi.org/10.1148/radiology.175.3.2343130">doi:10.1148/radiology.175.3.2343130</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/2343130">Pubmed</a>
  • 13. Kroon H & Schurmans J. Osteoblastoma: Clinical and Radiologic Findings in 98 New Cases. Radiology. 1990;175(3):783-90. <a href="https://doi.org/10.1148/radiology.175.3.2343130">doi:10.1148/radiology.175.3.2343130</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/2343130">Pubmed</a>
  • 7. Cerase A & Priolo F. Skeletal Benign Bone-Forming Lesions. Eur J Radiol. 1998;27 Suppl 1:S91-7. <a href="https://doi.org/10.1016/s0720-048x(98)00049-7">doi:10.1016/s0720-048x(98)00049-7</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/9652508">Pubmed</a>
  • 14. Cerase A & Priolo F. Skeletal Benign Bone-Forming Lesions. Eur J Radiol. 1998;27 Suppl 1:S91-7. <a href="https://doi.org/10.1016/s0720-048x(98)00049-7">doi:10.1016/s0720-048x(98)00049-7</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/9652508">Pubmed</a>
  • 8. Youssef B, Haddad M, Zahrani A et al. Osteoid Osteoma and Osteoblastoma: MRI Appearances and the Significance of Ring Enhancement. Eur Radiol. 1996;6(3):291-6. <a href="https://doi.org/10.1007/BF00180597">doi:10.1007/BF00180597</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/8797998">Pubmed</a>
  • 15. Youssef B, Haddad M, Zahrani A et al. Osteoid Osteoma and Osteoblastoma: MRI Appearances and the Significance of Ring Enhancement. Eur Radiol. 1996;6(3):291-6. <a href="https://doi.org/10.1007/BF00180597">doi:10.1007/BF00180597</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/8797998">Pubmed</a>
  • 10. Atesok K, Alman B, Schemitsch E, Peyser A, Mankin H. Osteoid Osteoma and Osteoblastoma. J Am Acad Orthop Surg. 2011;19(11):678-89. <a href="https://doi.org/10.5435/00124635-201111000-00004">doi:10.5435/00124635-201111000-00004</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/22052644">Pubmed</a>
  • 11. Crim J, Mirra J, Eckardt J, Seeger L. Widespread Inflammatory Response to Osteoblastoma: The Flare Phenomenon. Radiology. 1990;177(3):835-6. <a href="https://doi.org/10.1148/radiology.177.3.2243998">doi:10.1148/radiology.177.3.2243998</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/2243998">Pubmed</a>

Updates to Synonym Attributes

Updates to Synonym Attributes

Updates to Synonym Attributes

Title was added:
Aggressive osteoblastoma
Type was set to Synonym.
Visible was set to .
Content was set to .

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.